The newly proposed clinical and post-neoadjuvant treatment staging classifications for gastric adenocarcinoma for the American Joint Committee on Cancer (AJCC) staging
- PMID: 28948368
- DOI: 10.1007/s10120-017-0765-y
The newly proposed clinical and post-neoadjuvant treatment staging classifications for gastric adenocarcinoma for the American Joint Committee on Cancer (AJCC) staging
Abstract
Purpose: New stage grouping classifications for clinical (cStage) and post-neoadjuvant treatment (ypStage) stage for gastric adenocarcinoma have been proposed for the eighth edition of the AJCC manual. This article summarizes the analysis for these stages.
Methods: Gastric adenocarcinoma patients diagnosed in 2004-2009 were identified from the National Cancer Database (NCDB). The cStage cohort included both surgical and nonsurgical cases, and the ypStage cohort included only patients who had chemotherapy or radiation therapy before surgery. Survival differences between the stage groups were determined by the log-rank test and prognostic accuracy was assessed by concordance index. Analysis was performed using SAS 9.4 (SAS, Cary, NC, USA).
Results: Five strata for cStage and four strata for ypStage were developed. The 5-year survival rates for cStages were 56.77%, 47.39%, 33.1%, 25.9%, and 5.0% for stages I, IIa, IIb, III, and IV, respectively, and the rates for ypStage were 74.2%, 46.3%, 19.2%, and 11.6% for stages I, II, III, and IV, respectively. The log-rank test showed that survival differences were well stratified and stage groupings were ordered and distinct (p < 0.0001). The proposed cStage and ypStage classification was sensitive and specific and had high prognostic accuracy (cStage: c index = 0.81, 95% CI, 0.79-0.83; ypStage: c index = 0.80, 95% CI, 0.73-0.87).
Conclusion: The proposed eighth edition establishes two new staging schemata that provide essential prognostic data for patients before treatment and for patients who have undergone surgery following neoadjuvant therapy. These additions are a significant advance to the AJCC staging manual and will provide critical guidance to clinicians in making informed decisions throughout the treatment course.
Keywords: AJCC; Clinical stage (cStage); Gastric adenocarcinoma; Post-neoadjuvant treatment stage (ypStage); Staging.
Similar articles
-
Evaluation of the American Joint Committee on Cancer 8th edition staging system for gastric cancer patients after preoperative therapy.Gastric Cancer. 2018 Jan;21(1):74-83. doi: 10.1007/s10120-017-0743-4. Epub 2017 Jun 22. Gastric Cancer. 2018. PMID: 28643144 Free PMC article.
-
Providing Reliable Prognosis to Patients with Gastric Cancer in the Era of Neoadjuvant Therapies: Comparison of AJCC Staging Schemata.J Gastric Cancer. 2020 Dec;20(4):385-394. doi: 10.5230/jgc.2020.20.e41. Epub 2020 Dec 29. J Gastric Cancer. 2020. PMID: 33425440 Free PMC article.
-
Determinants of clinical outcomes of gastric cancer patients treated with neoadjuvant chemotherapy: a sub-analysis of the PRODIGY study.Gastric Cancer. 2022 Nov;25(6):1039-1049. doi: 10.1007/s10120-022-01325-6. Epub 2022 Aug 3. Gastric Cancer. 2022. PMID: 35920999
-
Recommendations for neoadjuvant pathologic staging (ypTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.Dis Esophagus. 2016 Nov;29(8):906-912. doi: 10.1111/dote.12538. Dis Esophagus. 2016. PMID: 27905170 Free PMC article.
-
Evaluation of the seventh AJCC TNM staging system for gastric cancer: a meta-analysis of cohort studies.Tumour Biol. 2014 Sep;35(9):8525-32. doi: 10.1007/s13277-014-1848-6. Epub 2014 Apr 3. Tumour Biol. 2014. PMID: 24696259 Review.
Cited by
-
Postoperative body weight change and its influencing factors in patients with gastric cancer.World J Gastrointest Surg. 2024 Jul 27;16(7):2242-2254. doi: 10.4240/wjgs.v16.i7.2242. World J Gastrointest Surg. 2024. PMID: 39087095 Free PMC article.
-
The safety and efficacy of carbon nanoparticle suspension injection versus indocyanine green tracer-guided lymph node dissection during radical gastrectomy (FUTURE-01): A single-center randomized controlled trial protocol.Front Oncol. 2023 Jan 6;12:1044854. doi: 10.3389/fonc.2022.1044854. eCollection 2022. Front Oncol. 2023. PMID: 36686792 Free PMC article.
-
Neoadjuvant PD-1 inhibitor plus apatinib and chemotherapy versus apatinib plus chemotherapy versus chemotherapy alone in patients with locally advanced gastric cancer.Am J Cancer Res. 2023 Aug 15;13(8):3559-3570. eCollection 2023. Am J Cancer Res. 2023. PMID: 37693166 Free PMC article.
-
Clinical significance of skip lymph-node metastasis in pN1 gastric-cancer patients after curative surgery.Gastroenterol Rep (Oxf). 2019 Jun;7(3):193-198. doi: 10.1093/gastro/goz008. Epub 2019 Mar 11. Gastroenterol Rep (Oxf). 2019. PMID: 31217983 Free PMC article.
-
Short-term outcomes of laparoscopic versus open total gastrectomy after neoadjuvant chemotherapy: a cohort study using the propensity score matching method.J Gastrointest Oncol. 2021 Apr;12(2):237-248. doi: 10.21037/jgo-20-374. J Gastrointest Oncol. 2021. PMID: 34012622 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical